Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dauphine Barone is active.

Publication


Featured researches published by Dauphine Barone.


Journal of Pharmacology and Experimental Therapeutics | 2004

Identification and characterization of 4-((4-(2-butynyloxy) phenyl)sulfonyl)-N-hydroxy-2,2-dimethyl-( 3S)-thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis

Yuhua Zhang; Jun Xu; Jeremy I. Levin; Martin Hegen; Guangde Li; Heidi Robertshaw; Fionula M. Brennan; Terri Cummons; Dave Clarke; Nichole Vansell; Cheryl Nickerson-Nutter; Dauphine Barone; Ken Mohler; Roy Black; Jerry Skotnicki; Jay Gibbons; Marc Feldmann; Philip Frost; Glenn Larsen; Lih-Ling Lin


Bioorganic & Medicinal Chemistry Letters | 2002

Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1′ group

Jeremy I. Levin; J.M. Chen; Mila T. Du; Frances Christy Nelson; Loran M. Killar; S. Skala; Amy Sung; Guixian Jin; R. Cowling; Dauphine Barone; C.J March; Kendall M. Mohler; Roy A. Black; Jerauld S. Skotnicki


Journal of Medicinal Chemistry | 2004

Synthesis and Structure−Activity Relationships of 4-alkynyloxy Phenyl Sulfanyl, Sulfinyl, and Sulfonyl Alkyl Hydroxamates as Tumor Necrosis Factor-α Converting Enzyme and Matrix Metalloproteinase Inhibitors

Aranapakam Mudumbai Venkatesan; Jamie Marie Davis; George Theodore Grosu; Jannie Lea Baker; Arie Zask; Jeremy I. Levin; John W. Ellingboe; Jerauld S. Skotnicki; John F. DiJoseph; Amy Sung; Guixian Jin; Weixin Xu; Diane Joseph Mccarthy; Dauphine Barone


Bioorganic & Medicinal Chemistry Letters | 2003

Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates

Jeremy I. Levin; J.M. Chen; K. Cheung; D. Cole; C. Crago; E.Delos Santos; Xuemei Du; Gulnaz Khafizova; Gloria Jean Macewan; C. Niu; E.J. Salaski; Arie Zask; Terri Cummons; Amy Sung; J. Xu; Y. Zhang; W. Xu; Semiramis Ayral-Kaloustian; Guixian Jin; R. Cowling; Dauphine Barone; Kendall M. Mohler; Roy A. Black; Jerauld S. Skotnicki


Archive | 2001

Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L

Kendall M. Mohler; Dauphine Barone; Jacques J. Peschon; Mary K. Kennedy; John D. Pluenneke


Bioorganic & Medicinal Chemistry Letters | 2006

Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates

Jeremy I. Levin; J.M. Chen; L.M. Laakso; Mila T. Du; J. Schmid; Weixin Xu; Terri Cummons; Jun Xu; Guixian Jin; Dauphine Barone; Jerauld S. Skotnicki


Bioorganic & Medicinal Chemistry Letters | 2003

Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors

Arie Zask; Yansong Gu; J.D. Albright; Xuemei Du; M. Hogan; Jeremy I. Levin; J.M. Chen; Loran M. Killar; Amy Sung; John F. DiJoseph; Michele A. Sharr; Catherine E Roth; S. Skala; Guixian Jin; R. Cowling; Kendall M. Mohler; Dauphine Barone; Roy A. Black; C.J March; Jerauld S. Skotnicki


Bioorganic & Medicinal Chemistry Letters | 2005

Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors

Arie Zask; Joshua Kaplan; Xuemei Du; Gloria Jean Macewan; Vincent Sandanayaka; Nancy H. Eudy; Jeremy I. Levin; Guixian Jin; Jun Xu; Terri Cummons; Dauphine Barone; Semiramis Ayral-Kaloustian; Jerauld S. Skotnicki


Archive | 2008

Human gm-csf antigen binding proteins

Dauphine Barone; Kenneth Brasel; Jose Carlos Escobar; Jacqueline Kirchner; Kara Olson


Bioorganic & Medicinal Chemistry Letters | 2004

Benzodiazepine inhibitors of the MMPs and TACE. Part 2.

Jeremy I. Levin; Frances Christy Nelson; Efren Delos Santos; Mila T. Du; Gloria Jean Macewan; James M. Chen; Semiramis Ayral-Kaloustian; Jun Xu; Guixian Jin; Terri Cummons; Dauphine Barone

Collaboration


Dive into the Dauphine Barone's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge